145 related articles for article (PubMed ID: 21566772)
21. Delivery of glucocorticoid conjugate in rat gastrointestinal tract and its treatment for ulcerative colitis.
Zhou SY; Mei QB; Liu L; Guo X; Qiu BS; Zhao DH; Cho CH
Acta Pharmacol Sin; 2001 Aug; 22(8):761-4. PubMed ID: 11749853
[TBL] [Abstract][Full Text] [Related]
22. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
[TBL] [Abstract][Full Text] [Related]
23. Budesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis.
Hoy SM
Drugs; 2015 May; 75(8):879-86. PubMed ID: 25920500
[TBL] [Abstract][Full Text] [Related]
24. Oral budesonide for induction of remission in ulcerative colitis.
Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of drugs used in the treatment of IBD and combinations thereof in acute DSS-induced colitis in mice.
Sann H; Erichsen Jv; Hessmann M; Pahl A; Hoffmeyer A
Life Sci; 2013 Apr; 92(12):708-18. PubMed ID: 23399699
[TBL] [Abstract][Full Text] [Related]
26. Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis.
Salice M; Rizzello F; Calabrese C; Privitera Hrustemovic H; Gionchetti P
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):607-613. PubMed ID: 31106602
[No Abstract] [Full Text] [Related]
27. Treatment of Suqingwan watered pill reduces colon injury induced by experimental colitis.
Han N; Li G; Kang R; Li Q; Liu Z; Jiang S; Yin J
J Ethnopharmacol; 2011 Jun; 136(1):144-8. PubMed ID: 21527334
[TBL] [Abstract][Full Text] [Related]
28. Development of novel budesonide pellets based on CODES(TM) technology: In vitro/in vivo evaluation in induced colitis in rats.
Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Rahmani N; Dorkoosh F; Mahzouni P
Daru; 2011; 19(2):107-17. PubMed ID: 22615647
[TBL] [Abstract][Full Text] [Related]
29. Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice.
Zhou J; Tan L; Xie J; Lai Z; Huang Y; Qu C; Luo D; Lin Z; Huang P; Su Z; Xie Y
Drug Deliv; 2017 Nov; 24(1):1667-1679. PubMed ID: 29078713
[TBL] [Abstract][Full Text] [Related]
30. The effects of crocin, mesalazine and their combination in the acetic acid-induced colitis in rats.
Faramarzpour A; Tehrani AA; Tamaddonfard E; Imani M
Vet Res Forum; 2019; 10(3):227-234. PubMed ID: 31737232
[TBL] [Abstract][Full Text] [Related]
31. [Novaferon ameliorates dextran sulfate sodium-induced colitis and downregulates expression of TNF-α in mice].
Li F; Wang W; Zhao Z; Zou Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 May; 40(5):504-10. PubMed ID: 26032070
[TBL] [Abstract][Full Text] [Related]
32. Grape seed extract reduces the severity of selected disease markers in the proximal colon of dextran sulphate sodium-induced colitis in rats.
Cheah KY; Bastian SE; Acott TM; Abimosleh SM; Lymn KA; Howarth GS
Dig Dis Sci; 2013 Apr; 58(4):970-7. PubMed ID: 23143736
[TBL] [Abstract][Full Text] [Related]
33. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
[TBL] [Abstract][Full Text] [Related]
34. Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis.
Naganuma M; Aoyama N; Suzuki Y; Nishino H; Kobayashi K; Hirai F; Watanabe K; Hibi T
J Crohns Colitis; 2016 Jul; 10(7):828-36. PubMed ID: 26577683
[TBL] [Abstract][Full Text] [Related]
35. Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats.
Liu CJ; Jin JD; Lv TD; Wu ZZ; Ha XQ
World J Gastroenterol; 2011 Jun; 17(21):2632-40. PubMed ID: 21677832
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic effect of a hydroxynaphthoquinone fraction on dextran sulfate sodium-induced ulcerative colitis.
Zhang ZL; Fan HY; Yang MY; Zhang ZK; Liu K
World J Gastroenterol; 2014 Nov; 20(41):15310-8. PubMed ID: 25386079
[TBL] [Abstract][Full Text] [Related]
37. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice.
Ocón B; Aranda CJ; Gámez-Belmonte R; Suárez MD; Zarzuelo A; Martínez-Augustin O; Sánchez de Medina F
Biochem Pharmacol; 2016 Sep; 116():73-88. PubMed ID: 27431777
[TBL] [Abstract][Full Text] [Related]
38. A safety evaluation of budesonide MMX for the treatment of ulcerative colitis.
Bezzio C; Festa S; Zerboni G; Papi C; Manes G; Saibeni S
Expert Opin Drug Saf; 2018 Apr; 17(4):437-444. PubMed ID: 29473429
[TBL] [Abstract][Full Text] [Related]
39. Effect of the macrolide antibacterial drug, tylosin, on TNBS-induced colitis in the rat.
Menozzi A; Pozzoli C; Poli E; Lazzaretti M; Cantoni A; Grandi D; Giovannini E; Coruzzi G
Pharmacology; 2005 Jun; 74(3):135-42. PubMed ID: 15756055
[TBL] [Abstract][Full Text] [Related]
40. In Vivo Evaluation of 5-ASA Colon-Specific Tablets Using Experimental-Induced Colitis Rat Animal Model.
Sawarkar SP; Deshpande SG; Bajaj AN; Nikam VS
AAPS PharmSciTech; 2015 Dec; 16(6):1445-54. PubMed ID: 26017284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
